← Fund selection & CIO-office support
Different funds.
How different are
the risks?
WSP examines your holdings as one portfolio. See repeated exposures, concentration risks and the actions worth considering.
Discuss a portfolio reviewScope, deliverables and fee agreed before work starts.
Different funds. Shared exposures.
3.2%+Fund B
1.8%→Issuer X
5.0%
Contributions to total portfolio value · fictional example
Illustrative example · no client information or investment recommendation.
Your holdings, examined. This assignment reviews your portfolio. WSP’s maintained model portfolios ↗ are a separate research record.
What you receive.
An exposure map
Underlying issuer and sector exposures across the holdings covered.
A written WSP view
Which concentrations matter, what is uncertain and how holdings serve their intended roles.
A prioritised action brief
Recommended next steps, options to examine and a discussion with your team.
See through the fund names.
Fictional holdings and client limits. A sample review, not a recommendation for a real portfolio.
The fund count overstates the diversification.
Funds A and B repeat an issuer and exceed the example technology limit. Examine resizing options before adding exposure; overlap alone does not justify replacement.
One issuer. Two routes.
3.2%+B
1.8%
WSP action: track Issuer X once across all holdings; assess further purchases on that combined exposure.
Show the holdings calculation
Fund A is 40% of the portfolio and holds 8% in Issuer X: 40% × 8% = 3.2%. Fund B is 30% of the portfolio and holds 6% in Issuer X: 30% × 6% = 1.8%. Total = 5.0%. The fictional bond sleeve and cash hold none. The 6% issuer limit is an invented client mandate limit, not a legal standard. This is exposure to one shared issuer, not a measure of all portfolio overlap.
38% in technology.
Contributions in percentage points of total portfolio
WSP action: compare resizing and replacement options; show the effect on sector exposure, costs and intended portfolio roles.
Show the limit and calculation
Technology is 50% of Fund A and 60% of Fund B: (40% × 50%) + (30% × 60%) = 20% + 18% = 38% of total portfolio. The fictional bond sleeve and cash have no technology exposure. The 30% cap is an invented client mandate limit, not a regulatory requirement. The excess is 8 percentage points of total portfolio value; it is not an instruction to sell 8% of either fund.
Keep both for a reason.
Core equityFund B
Growth satellite
WSP action: test whether Fund B adds a useful exposure after allowing for shared issuers and technology concentration.
What this evidence cannot tell us
These intended roles are fictional. A shared issuer and a sector total do not establish correlation, factor exposure, manager skill or stress losses. A commissioned review examines agreed holdings coverage and dates; additional factor, performance or scenario analysis is scoped separately. The recommendation may be to retain both with revised sizes, replace one or keep the structure with a documented rationale.
Finding → options → decision.
Scope and evidence behind the report
Sample assumptions: one common holdings date, fully invested unlevered long-only funds, no derivatives, no unreported issuer or technology exposure. Sources in a real report include dated portfolio positions, underlying fund holdings, mandate limits and agreed classification rules. Missing or stale holdings are identified as coverage gaps. Currency, liquidity, credit, duration, leverage and other risks are not analysed in this example. A review is not an assurance that every risk has been found.
Bring the decision.
Agree the work.
Brief → Scope, fee and timing → WSP view + discussion
What to send us
Start with the portfolio’s objectives, base currency, constraints, holdings date and decision you face. WSP agrees a secure channel for positions, weights, fund identifiers and mandate limits; underlying fund data availability determines look-through coverage.
Scope, fee and timing
Before work starts, agree the exposures to review, available data, written outputs, discussion, fee and target date. Portfolio review is a defined assignment. Model construction, implementation and recurring monitoring are separate scopes.
Independent judgement
WSP assesses relevant relationships and conflicts before an independent review. A review of a model WSP itself designed is identified as a quality check, not an independent assessment.
Your institution retains investment decisions, implementation and client-specific suitability. The fictional report illustrates the agreed review output; it does not prescribe an allocation for a real client.